NRSN•benzinga•
NeuroSense Therapeutics FY 2024 GAAP EPS $(0.54) Beats $(0.60) Estimate
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 7, 2025 by benzinga